e-Drug3D

602

CLOFAZIMINE

DISCONTINUED


INN
CLOFAZIMINE

cas 2030-63-9
CLASS

ANTIINFECTIVES
ANTIMYCOBACTERIALS
LEPROSTATIC AGENTS
ANTI-INFLAMMATORY
TREATMENT OF LEPROMATOUS LEPROSY

ROUTE (list)

ORAL

ATC code

J04BA01
J04BA51

PK parameters

F 53 PERCENT
Tmax 10 HOUR
t1/2 1680 HOUR

Solubility

INSOLUBLE IN WATER


Target

TARGET DNA

DrugCentral

Unknown

Download SDF file N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine

Formula:
C27H22Cl2N4

Calculated chemical properties:

MW 473.39
NB_atoms 33
XLogP 7.49
PSA 34.285
NB_HD 1
NB_HA 4
fsp3 0.11
Lipinski(0=no;1=yes) 0

FDA
NDA 019500 (label) INN (CLOFAZIMINE) LAMPRENE (NOVARTIS) APPROVAL= AP YEAR= 1986 NEWMOLECULARENTITY DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL